Safeway Pharmacy #1142 | |
12519 Ne 85th St, Kirkland, Washington 98033 | |
(425) 822-9235 |
Name | Safeway Pharmacy #1142 |
---|---|
Organization Name | Safeway Inc |
Location | 12519 Ne 85th St, Kirkland, Washington 98033 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (425) 822-9235 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
LUNGevity, the nation's leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable.
Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change' programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.
Many viral infections are nipped in the bud by the innate immune response. This involves specific proteins within the infected cell that recognize the virus and trigger a signalling cascade - the so-called interferon response. This activates a protective mechanism in neighbouring cells and often results in the death of the primarily infected cell.
› Verified 2 days ago
NPI Number | 1831135466 |
Organization Name | SAFEWAY INC |
Doing Business As | SAFEWAY PHARMACY #1142 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 12519 Ne 85th St, Kirkland, WA 98033 |
Phone Number | 425-822-9235 |
News Archive
LUNGevity, the nation's leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable.
Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change' programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.
Many viral infections are nipped in the bud by the innate immune response. This involves specific proteins within the infected cell that recognize the virus and trigger a signalling cascade - the so-called interferon response. This activates a protective mechanism in neighbouring cells and often results in the death of the primarily infected cell.
› Verified 2 days ago
News Archive
LUNGevity, the nation's leading lung cancer-focused nonprofit organization today launched a new mobile application designed to make understanding and living with lung cancer less daunting and considerably more manageable.
Health Secretary John Reid said that the 4,000 beds that have been freed up since the ‘Cash for Change' programme was introduced in 2001 was equivalent to adding eight extra hospitals to the NHS. The scheme provided £300m to local councils to ensure that people leaving hospital would get the care they needed.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.
Many viral infections are nipped in the bud by the innate immune response. This involves specific proteins within the infected cell that recognize the virus and trigger a signalling cascade - the so-called interferon response. This activates a protective mechanism in neighbouring cells and often results in the death of the primarily infected cell.
› Verified 2 days ago
Fred Meyer Pharmacy # 391 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12221 120th Ave, Kirkland, Washington 98034 Phone: (425) 820-3233 | |
Qfc Pharmacy #828 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11224ne124th St, Kirkland, Washington 98034 Phone: (425) 820-0440 | |
Qfc Pharmacy 894 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 425 Urban Plz, Kirkland, Washington 98033 Phone: (425) 822-4123 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12039 Ne 128th St, Kirkland, Washington 98034 Phone: (425) 814-3258 | |
Northwest Eye Design Llc Type: Prosthetic/Orthotic Supplier Location: 12911 120th Ave Ne, Kirkland, Washington 98034 Phone: (425) 823-1861 |